Aurion Biotechnologies
Latest round
- Series C
Last raised
- Apr 2022
Total raised
- $55M
Investors
- 6
About Aurion Biotechnologies
Based in Washington, US, and founded in 2022, Aurion Biotechnologies, also known as Aurion Biotech, offers regenerative therapies to cure blindness. As of May 2022, the firm operates from Seattle, Washington, Cambridge, Massachusetts, and Tokyo, and Greg Kunst is the CEO. The company provides cell therapy for corneal endothelial disease using its proprietary technology Vyznova ™ which cultures healthy cells from a donor’s cornea and manufactures treatments for more than a hundred recipient eyes at a faster rate and with less eye invasion.
Who invested in Aurion Biotechnologies
6 investors across 1 round
See all investors in Aurion Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Apr 5, 2022
Amount
$55M
Investors
Questions about Aurion Biotechnologies
Who invested in Aurion Biotechnologies?
Aurion Biotechnologies has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aurion Biotechnologies raised?
Aurion Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aurion Biotechnologies last raise money?
Aurion Biotechnologies's most recent round on record is a Series C, in Apr 2022.
What does Aurion Biotechnologies do?
Based in Washington, US, and founded in 2022, Aurion Biotechnologies, also known as Aurion Biotech, offers regenerative therapies to cure blindness.
Where is Aurion Biotechnologies headquartered?
Aurion Biotechnologies is headquartered in Seattle, US.
Which VCs invest in companies like Aurion Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aurion Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Aurion Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.